These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 37247301)
1. HPV Vaccination and Cervical Cancer Screening Policies and Practices in 18 Countries, Territories and Entities across Eastern Europe and Central Asia. Davies P; Aluloski I; Arifdjanova D; Brcanski J; Davidzenka A; Durdyeva A; Gayrat Umarzoda S; Goshliyev K; Jovanovic V; Jugeli L; Kocinaj-Berisha M; Maistruk G; Naumovic T; Pilav A; Rzayeva G; Saribekyan K; Siljak S; Ten E; Valuta D; Veljkovic M; Yildirimkaya G; Ylli A; Zhylkaidarova A; Melnic E Asian Pac J Cancer Prev; 2023 May; 24(5):1781-1788. PubMed ID: 37247301 [TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia. Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297 [TBL] [Abstract][Full Text] [Related]
3. Update on HPV Vaccination Policies and Practices in 17 Eastern European and Central Asian Countries and Territories. Davies P; Aluloski I; Aluloski D; Dizdarevic Maksumic A; Ghayrat Umarzoda S; Gutu V; Ilmammedova M; Janashia A; Kocinaj-Berisha M; Matylevich O; Pidverbetskyy B; Rzayeva G; Sahakyan G; Siljak S; Ten E; Veljkovic M; Yildirimkaya G; Ylli A; Zhylkaidarova A; Melnic E Asian Pac J Cancer Prev; 2023 Dec; 24(12):4227-4235. PubMed ID: 38156858 [TBL] [Abstract][Full Text] [Related]
4. Patterns and trends in human papillomavirus-related diseases in Central and Eastern Europe and Central Asia. Bray F; Lortet-Tieulent J; Znaor A; Brotons M; Poljak M; Arbyn M Vaccine; 2013 Dec; 31 Suppl 7():H32-45. PubMed ID: 24332296 [TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia. Berkhof J; Bogaards JA; Demirel E; Diaz M; Sharma M; Kim JJ Vaccine; 2013 Dec; 31 Suppl 7():H71-9. PubMed ID: 24332299 [TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe. Poljak M; Seme K; Maver PJ; Kocjan BJ; Cuschieri KS; Rogovskaya SI; Arbyn M; Syrjänen S Vaccine; 2013 Dec; 31 Suppl 7():H59-70. PubMed ID: 24332298 [TBL] [Abstract][Full Text] [Related]
7. Recommendations for cervical cancer prevention in Asia Pacific. Garland SM; Cuzick J; Domingo EJ; Goldie SJ; Kim YT; Konno R; Parkin DM; Qiao YL; Sankaranarayanan R; Stern PL; Tay SK; Bosch FX Vaccine; 2008 Aug; 26 Suppl 12():M89-98. PubMed ID: 18945418 [TBL] [Abstract][Full Text] [Related]
8. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds. C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804 [TBL] [Abstract][Full Text] [Related]
9. Breast and cervical cancer screening practices in nine countries of Eastern Europe and Central Asia: A population-based survey. Znaor A; Ryzhov A; Losada ML; Carvalho A; Smelov V; Barchuk A; Valkov M; Ten E; Andreasyan D; Zhizhilashvili S; Dushimova Z; Zhuikova LD; Egorova A; Yaumenenka A; Djanklich S; Tril O; Bray F; Corbex M J Cancer Policy; 2023 Dec; 38():100436. PubMed ID: 37544479 [TBL] [Abstract][Full Text] [Related]
10. Mapping HPV Vaccination and Cervical Cancer Screening Practice in the Pacific Region-Strengthening National and Regional Cervical Cancer Prevention. Obel J; McKenzie J; Buenconsejo-Lum LE; Durand AM; Ekeroma A; Souares Y; Hoy D; Baravilala W; Garland SM; Kjaer SK; Roth A Asian Pac J Cancer Prev; 2015; 16(8):3435-42. PubMed ID: 25921158 [TBL] [Abstract][Full Text] [Related]
11. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Brisson M; Kim JJ; Canfell K; Drolet M; Gingras G; Burger EA; Martin D; Simms KT; Bénard É; Boily MC; Sy S; Regan C; Keane A; Caruana M; Nguyen DTN; Smith MA; Laprise JF; Jit M; Alary M; Bray F; Fidarova E; Elsheikh F; Bloem PJN; Broutet N; Hutubessy R Lancet; 2020 Feb; 395(10224):575-590. PubMed ID: 32007141 [TBL] [Abstract][Full Text] [Related]
12. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Canfell K; Kim JJ; Brisson M; Keane A; Simms KT; Caruana M; Burger EA; Martin D; Nguyen DTN; Bénard É; Sy S; Regan C; Drolet M; Gingras G; Laprise JF; Torode J; Smith MA; Fidarova E; Trapani D; Bray F; Ilbawi A; Broutet N; Hutubessy R Lancet; 2020 Feb; 395(10224):591-603. PubMed ID: 32007142 [TBL] [Abstract][Full Text] [Related]
13. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors]. Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243 [TBL] [Abstract][Full Text] [Related]
14. HPV-FASTER: broadening the scope for prevention of HPV-related cancer. Bosch FX; Robles C; Díaz M; Arbyn M; Baussano I; Clavel C; Ronco G; Dillner J; Lehtinen M; Petry KU; Poljak M; Kjaer SK; Meijer CJ; Garland SM; Salmerón J; Castellsagué X; Bruni L; de Sanjosé S; Cuzick J Nat Rev Clin Oncol; 2016 Feb; 13(2):119-32. PubMed ID: 26323382 [TBL] [Abstract][Full Text] [Related]
15. The European response to the WHO call to eliminate cervical cancer as a public health problem. Arbyn M; Gultekin M; Morice P; Nieminen P; Cruickshank M; Poortmans P; Kelly D; Poljak M; Bergeron C; Ritchie D; Schmidt D; Kyrgiou M; Van den Bruel A; Bruni L; Basu P; Bray F; Weiderpass E Int J Cancer; 2021 Jan; 148(2):277-284. PubMed ID: 32638362 [TBL] [Abstract][Full Text] [Related]
16. Screening and prevention of HPV-related anogenital cancers in women living with HIV in Europe: Results from a systematic review. Krankowska D; Mazzitelli M; Ucak HA; Orviz E; Karakoc HN; Mortimer H; Aebi-Popp K; Gilleece Y HIV Med; 2024 Jul; 25(7):769-793. PubMed ID: 38238990 [TBL] [Abstract][Full Text] [Related]
17. Cervical cancer screening of HPV vaccinated populations: Cytology, molecular testing, both or none. El-Zein M; Richardson L; Franco EL J Clin Virol; 2016 Mar; 76 Suppl 1(Suppl 1):S62-S68. PubMed ID: 26631958 [TBL] [Abstract][Full Text] [Related]
18. Prevention of Cervical Cancer in Low-Resource African Settings. Mulongo M; Chibwesha CJ Obstet Gynecol Clin North Am; 2022 Dec; 49(4):771-781. PubMed ID: 36328679 [TBL] [Abstract][Full Text] [Related]
19. Adapting cervical cancer screening for women vaccinated against human papillomavirus infections: The value of stratifying guidelines. Pedersen K; Burger EA; Nygård M; Kristiansen IS; Kim JJ Eur J Cancer; 2018 Mar; 91():68-75. PubMed ID: 29335156 [TBL] [Abstract][Full Text] [Related]
20. What's next? Perspectives and future needs of cervical screening in Europe in the era of molecular testing and vaccination. Lynge E; Antilla A; Arbyn M; Segnan N; Ronco G Eur J Cancer; 2009 Oct; 45(15):2714-21. PubMed ID: 19695870 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]